Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery

被引:103
作者
Bhattarai, Narayan [1 ]
Ramay, Hassna R. [1 ]
Chou, Shinn-Huey [2 ]
Zhang, Miqin [1 ]
机构
[1] Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA
[2] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2006年 / 1卷 / 02期
关键词
chitosan; lactic acid-g-chitosan; drug delivery; nanoparticles;
D O I
10.2147/nano.2006.1.2.181
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Nanoparticles of similar to 10nm in diameter made with chitosan or lacticacid-grafted chitosan were developed for high drug loading and prolonged drug release. A drug encapsulation efficiency of 92% and a release rate of 28% from chitosan nanoparticles over a 4-week period were demonstrated with bovine serum protein. To further increase drug encapsulation, prolong drug release, and increase chitosan solubility in solution of neutral pH, chitosan was modified with lactic acid by grafting D,L-lactic acid onto amino groups in chitosan without using a catalyst. The lactic acid-grafted chitosan nanoparticles demonstrated a drug encapsulation efficiency of 92% and a protein release rate of 15% over 4 weeks. With increased protein concentration, the drug encapsulation efficiency decreased and drug release rate increased. Unlike chitosan, which is generally soluble only in acid solution, the chitosan modified with lactic acid can be prepared from solutions of neutral pH, offering an additional advantage of allowing proteins or drugs to be uniformly incorporated in the matrix structure with minimal or no denaturization.
引用
收藏
页码:181 / 187
页数:7
相关论文
共 27 条
[1]   EFFECT OF CHITOSAN ON THE PERMEABILITY OF MONOLAYERS OF INTESTINAL EPITHELIAL-CELLS (CACO-2) [J].
ARTURSSON, P ;
LINDMARK, T ;
DAVIS, SS ;
ILLUM, L .
PHARMACEUTICAL RESEARCH, 1994, 11 (09) :1358-1361
[2]   Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for antiinflammatory drugs [J].
Berthold, A ;
Cremer, K ;
Kreuter, J .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (01) :17-25
[3]   A NOVEL-APPROACH TO THE ORAL DELIVERY OF MICRO-PARTICLES OR NANOPARTICLES [J].
BODMEIER, R ;
CHEN, HG ;
PAERATAKUL, O .
PHARMACEUTICAL RESEARCH, 1989, 6 (05) :413-417
[4]   The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro [J].
Borchard, G ;
Luessen, HL ;
deBoer, AG ;
Verhoef, JC ;
Lehr, CM ;
Junginger, HE .
JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) :131-138
[5]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[6]  
2-4
[7]   Pharmaceutical applications of chitosan [J].
Dodane, V ;
Vilivalam, VD .
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (06) :246-253
[8]   Hydrogels for tissue engineering: scaffold design variables and applications [J].
Drury, JL ;
Mooney, DJ .
BIOMATERIALS, 2003, 24 (24) :4337-4351
[9]   Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization [J].
Janes, KA ;
Alonso, MJ .
JOURNAL OF APPLIED POLYMER SCIENCE, 2003, 88 (12) :2769-2776
[10]   Polysaccharide colloidal particles as delivery systems for macromolecules [J].
Janes, KA ;
Calvo, P ;
Alonso, MJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (01) :83-97